Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BETA CARE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   1.3% 1.3% 1.3% 1.3% 1.3% 1.3% 1.3% 1.3%   Bankruptcy risk   6.6% 5.1% 7.1% 5.7% 3.7% 7.6% 11.3% 11.1%   Credit score (0-100)   37 43 33 39 51 32 21 22   Credit rating   BBB BBB BBB BBB BBB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   511 710 759 612 757 635 0.0 0.0   EBITDA   43.6 230 197 50.1 131 105 0.0 0.0   EBIT   29.9 212 197 50.1 122 67.7 0.0 0.0   Pre-tax profit (PTP)   29.8 210.4 189.2 46.3 122.0 67.7 0.0 0.0   Net earnings   22.4 162.5 146.4 34.2 93.3 51.1 0.0 0.0   Pre-tax profit without non-rec. items   29.8 210 189 46.3 122 67.7 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 46.2 247 0.0 0.0   Shareholders equity total   413 575 722 756 849 900 820 820   Interest-bearing liabilities   0.0 226 504 232 412 306 0.0 0.0   Balance sheet total (assets)   850 1,073 1,409 1,169 1,487 1,296 820 820   Net Debt   -316 -402 241 -449 -350 178 -820 -820     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   511 710 759 612 757 635 0.0 0.0   Gross profit growth   -14.4% 39.1% 6.9% -19.4% 23.6% -16.1% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   850 1,073 1,409 1,169 1,487 1,296 820 820   Balance sheet change%   18.1% 26.3% 31.3% -17.0% 27.1% -12.8% -36.7% 0.0%   Added value   43.6 230.4 197.2 50.1 122.0 104.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -14 -18 0 0 37 164 -247 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   5.9% 29.8% 26.0% 8.2% 16.1% 10.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.8% 22.1% 15.9% 4.0% 9.2% 4.9% 0.0% 0.0%   ROI %   7.4% 34.9% 19.4% 4.7% 10.8% 5.5% 0.0% 0.0%   ROE %   5.6% 32.9% 22.6% 4.6% 11.6% 5.8% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   48.6% 53.6% 51.2% 64.7% 57.1% 69.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -725.6% -174.6% 122.1% -897.2% -266.0% 169.9% 0.0% 0.0%   Gearing %   0.0% 39.4% 69.9% 30.7% 48.5% 33.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   20.6% 1.5% 2.2% 1.6% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   1.8 2.1 1.9 2.7 1.8 2.7 0.0 0.0   Current Ratio   2.0 2.2 2.1 2.8 2.3 2.7 0.0 0.0   Cash and cash equivalent   316.1 628.8 263.7 681.6 761.4 127.8 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   417.4 575.4 721.8 756.0 823.8 662.5 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   44 230 197 50 122 105 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   44 230 197 50 131 105 0 0   EBIT / employee   30 212 197 50 122 68 0 0   Net earnings / employee   22 162 146 34 93 51 0 0